08/05/2022
Breaking News: FDA Approves Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer
Today, the FDA approved darolutamide in combination with docetaxel chemotherapy for patients with metastatic hormone-sensitive prostate cancer (mHSPC). This means that patients with mHSPC (prostate cancer that has spread beyond the prostate and is responsive to hormone therapy, or who have not yet received hormone therapy) have an additional treatment. Read More
07/28/2022
August Episode of “The Prostate Health Show” on SiriusXM Covers Risk Factors for Prostate Cancer
Got questions about prostate health and prostate cancer? The Prostate Cancer Foundation, Sirius XM’s Doctor Radio channel, and NYU Langone Health are partnering on a monthly prostate health radio series. Our host is PCF-funded researcher and practicing urologist Stacy Loeb, MD, MSc, PhD (Hon.) longtime host of the popular “Men’s. Read More
07/26/2022
Researchers Identify a New Subtype of Advanced Prostate Cancer
A PCF-funded study published in the prestigious journal Science has identified a new subtype of castration-resistant prostate cancer (CRPC). Understanding how genes and proteins “drive” this particular type of cancer may lead to new treatments. In the early stages, prostate cancer cells are driven by androgens (e.g., testosterone), which naturally. Read More
07/18/2022
Plant-Based Diets and Prostate Cancer
“Plant-based” foods are increasingly on the radar. You can grab a green juice at most chain coffee shops, a decent salad at airport restaurants, or a “McPlant” (Impossible) burger at the Golden Arches in some locations. And at many local grocery stores or farmers’ markets, you can purchase ingredients to. Read More
07/13/2022
Does Testosterone Cause Prostate Cancer?
As men age, their testosterone levels can fall: by one estimate, 39% of men aged 45-85 have blood testosterone levels considered low (less than 300 ng/mL). Many have no symptoms, but some men may experience symptoms such as low mood, low energy, weight gain, and low sex drive, leading them. Read More
07/11/2022
Meet Chuck Ryan, M.D.
“I don’t think we’ve ever been in a more exciting time in prostate cancer and oncology, with advances in targeted therapies, hormonal therapies, cellular therapies, radioligand therapies. We don’t know what’s the next big thing, but we know that all of those approaches can be refined even further. We’ve got. Read More
07/08/2022
Southwestern Black Bean and Corn Salad
It’s the peak of summer, bringing BBQs, potlucks, and family gatherings. If you’re looking for a quick and healthy recipe that you can easily scale up for a crowd, make this salad your go-to contribution for the rest of the season. This colorful mix of black beans, corn, onions, bell. Read More
Southwestern Black Bean and Corn Salad
Download the recipe card Southwestern Black Bean and Corn Salad Prep Time: 20 minutes Chilling Time: At least 30 minutes Serves: 8 as a side dish Ingredients: 3 cups cooked black beans (or 2 15-ounce cans, rinsed and drained) 1 ½ cups corn kernels (or 1 can, drained) 1 red. Read More
07/07/2022
Home-based Exercise Programs for Cancer Survivors Show Promise
Exercise participation among cancer survivors has been shown to improve quality of life and physical functioning, yet only 10%-30% of survivors meet physical activity guidelines. In prostate cancer, aerobic exercise after prostate cancer diagnosis may reduce the risk of prostate cancer recurrence or death by up to 60 percent. Sedentary. Read More
07/05/2022
Robert & Susan Hollander Foundation Supports Prostate Cancer Research
When Dr. Robert Hollander was diagnosed with prostate cancer, he wanted to channel his passion for winemaking to support prostate cancer research. He is now preparing to launch new barrels of his small batch Zinfandel and Syrah wines while raising critical funding for PCF. Learn more at: https://www.indiegogo.com/projects/2redwines-supporting-prostate-cancer-research-2022#/ https://youtu.be/PQTm2n2rmzc Read More